MMWR Morb Mortal Wkly Rep. 2013 Apr 12;62(14):261-3.
Varicella usually is a self-limited disease but sometimes can result in severe complications and death. Although infants, adults, and immunocompromised persons are at increased risk for severe disease, before varicella vaccine was introduced in 1995, the majority of hospitalizations and deaths from varicella occurred among healthy persons aged <20 years. Introduction of varicella vaccine has substantially decreased varicella incidence, hospitalizations, and deaths in the United States. This report describes a varicella death in an unvaccinated, previously healthy adolescent aged 15 years. In April 2012, as part of the routine review of vital statistics records, the Ohio Department of Health identified a 2009 death with the International Classification of Diseases, 10th Revision code for varicella as the underlying cause. Because varicella deaths are nationally reportable, the Ohio Department of Health conducted an investigation to validate that the coding was accurate. Investigators learned that, on March 12, 2009, the adolescent girl was admitted to a hospital with a 3-day history of a rash consistent with varicella and a 1-day history of fever and shortness of breath. The patient was started on intravenous acyclovir (on day 4 of illness) and broad-spectrum antibiotics and antifungals, but she died 3 weeks later. The case underscores the importance of varicella vaccination, including catch-up vaccination of older children and adolescents, to prevent varicella and its serious complications.
水痘通常是一种自限性疾病,但有时会导致严重并发症和死亡。虽然婴儿、成人和免疫功能低下者患严重疾病的风险增加,但在 1995 年水痘疫苗问世之前,大多数因水痘住院和死亡的病例发生在<20 岁的健康人群中。水痘疫苗的引入大大降低了美国水痘的发病率、住院率和死亡率。本报告描述了一例未接种疫苗、既往健康的 15 岁青少年的水痘死亡病例。2012 年 4 月,作为常规审查生命统计记录的一部分,俄亥俄州卫生部门发现了一个 2009 年的死亡病例,其国际疾病分类第 10 版编码为水痘为根本原因。由于水痘死亡是全国报告的,俄亥俄州卫生部门进行了调查以验证编码的准确性。调查人员了解到,2009 年 3 月 12 日,这名少女因皮疹持续 3 天(符合水痘症状)和发热、呼吸急促 1 天而入院。患者开始接受静脉注射阿昔洛韦(发病第 4 天)和广谱抗生素和抗真菌药物治疗,但 3 周后死亡。该病例强调了水痘疫苗接种的重要性,包括对大龄儿童和青少年的补种,以预防水痘及其严重并发症。